GO:0005829 | cytosol | 2.57e-05 | 3.71e-01 | 2.209 | 8 | 132 | 2496 |
GO:0043022 | ribosome binding | 1.50e-04 | 1.00e+00 | 6.739 | 2 | 3 | 27 |
GO:0070062 | extracellular vesicular exosome | 2.63e-04 | 1.00e+00 | 2.073 | 7 | 104 | 2400 |
GO:0016020 | membrane | 3.44e-04 | 1.00e+00 | 2.364 | 6 | 90 | 1681 |
GO:0004151 | dihydroorotase activity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 6.93e-04 | 1.00e+00 | 10.494 | 1 | 1 | 1 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 2 | 2 |
GO:0005055 | laminin receptor activity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 2 |
GO:0006414 | translational elongation | 1.79e-03 | 1.00e+00 | 4.955 | 2 | 13 | 93 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0000015 | phosphopyruvate hydratase complex | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 3 |
GO:0004634 | phosphopyruvate hydratase activity | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 3 |
GO:0030529 | ribonucleoprotein complex | 2.58e-03 | 1.00e+00 | 4.687 | 2 | 8 | 112 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 4 |
GO:0051414 | response to cortisol | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 3 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0006323 | DNA packaging | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 2 | 5 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0031415 | NatA complex | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 5 |
GO:0044267 | cellular protein metabolic process | 3.56e-03 | 1.00e+00 | 3.190 | 3 | 29 | 474 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 3 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 4.52e-03 | 1.00e+00 | 4.275 | 2 | 32 | 149 |
GO:0005654 | nucleoplasm | 4.58e-03 | 1.00e+00 | 2.415 | 4 | 76 | 1082 |
GO:0000028 | ribosomal small subunit assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0006475 | internal protein amino acid acetylation | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 7 |
GO:0016032 | viral process | 4.98e-03 | 1.00e+00 | 3.018 | 3 | 55 | 534 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 8 |
GO:0008080 | N-acetyltransferase activity | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 8 |
GO:0006228 | UTP biosynthetic process | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0014075 | response to amine | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 9 |
GO:0008494 | translation activator activity | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 9 |
GO:0031625 | ubiquitin protein ligase binding | 6.39e-03 | 1.00e+00 | 4.018 | 2 | 14 | 178 |
GO:0044281 | small molecule metabolic process | 6.88e-03 | 1.00e+00 | 2.252 | 4 | 58 | 1211 |
GO:0006098 | pentose-phosphate shunt | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 4 | 10 |
GO:0016407 | acetyltransferase activity | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 1 | 10 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 6.91e-03 | 1.00e+00 | 7.172 | 1 | 1 | 10 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 4 | 11 |
GO:0043403 | skeletal muscle tissue regeneration | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 11 |
GO:0005838 | proteasome regulatory particle | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 7 | 12 |
GO:0005662 | DNA replication factor A complex | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 13 |
GO:0010467 | gene expression | 9.33e-03 | 1.00e+00 | 2.693 | 3 | 59 | 669 |
GO:0035267 | NuA4 histone acetyltransferase complex | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 4 | 14 |
GO:0016071 | mRNA metabolic process | 9.87e-03 | 1.00e+00 | 3.693 | 2 | 31 | 223 |
GO:0006412 | translation | 1.05e-02 | 1.00e+00 | 3.649 | 2 | 20 | 230 |
GO:0050998 | nitric-oxide synthase binding | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 16 |
GO:0006541 | glutamine metabolic process | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 17 |
GO:0003746 | translation elongation factor activity | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 8 | 17 |
GO:0016070 | RNA metabolic process | 1.20e-02 | 1.00e+00 | 3.546 | 2 | 32 | 247 |
GO:0035861 | site of double-strand break | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 18 |
GO:0017144 | drug metabolic process | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 18 |
GO:0005975 | carbohydrate metabolic process | 1.26e-02 | 1.00e+00 | 3.511 | 2 | 9 | 253 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.31e-02 | 1.00e+00 | 6.246 | 1 | 1 | 19 |
GO:0006281 | DNA repair | 1.33e-02 | 1.00e+00 | 3.466 | 2 | 18 | 261 |
GO:0006298 | mismatch repair | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 3 | 20 |
GO:0005634 | nucleus | 1.44e-02 | 1.00e+00 | 1.147 | 7 | 136 | 4559 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 5 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 4 | 21 |
GO:0019899 | enzyme binding | 1.49e-02 | 1.00e+00 | 3.380 | 2 | 12 | 277 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 3 | 22 |
GO:0033574 | response to testosterone | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 4 | 23 |
GO:0005844 | polysome | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 4 | 23 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 23 |
GO:0043234 | protein complex | 1.68e-02 | 1.00e+00 | 3.290 | 2 | 18 | 295 |
GO:0000722 | telomere maintenance via recombination | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 5 | 25 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 3 | 26 |
GO:0050661 | NADP binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 4 | 27 |
GO:0019901 | protein kinase binding | 1.93e-02 | 1.00e+00 | 3.186 | 2 | 21 | 317 |
GO:0019894 | kinesin binding | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 1.99e-02 | 1.00e+00 | 5.636 | 1 | 1 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 7 | 30 |
GO:0001895 | retina homeostasis | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 36 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 4 | 37 |
GO:0006284 | base-excision repair | 2.54e-02 | 1.00e+00 | 5.285 | 1 | 3 | 37 |
GO:0006096 | glycolytic process | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 4 | 38 |
GO:0070527 | platelet aggregation | 2.60e-02 | 1.00e+00 | 5.246 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 4 | 39 |
GO:0000781 | chromosome, telomeric region | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 3 | 39 |
GO:0007595 | lactation | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 39 |
GO:0043195 | terminal bouton | 2.81e-02 | 1.00e+00 | 5.137 | 1 | 1 | 41 |
GO:0000278 | mitotic cell cycle | 2.86e-02 | 1.00e+00 | 2.883 | 2 | 48 | 391 |
GO:0006094 | gluconeogenesis | 2.94e-02 | 1.00e+00 | 5.068 | 1 | 5 | 43 |
GO:0021762 | substantia nigra development | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 3 | 44 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 7 | 46 |
GO:0035690 | cellular response to drug | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 2 | 49 |
GO:0003684 | damaged DNA binding | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 7 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 17 | 50 |
GO:0031100 | organ regeneration | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 4 | 50 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.62e-02 | 1.00e+00 | 4.766 | 1 | 5 | 53 |
GO:0002244 | hematopoietic progenitor cell differentiation | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 1 | 54 |
GO:0045216 | cell-cell junction organization | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 54 |
GO:0000724 | double-strand break repair via homologous recombination | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 3 | 55 |
GO:0000723 | telomere maintenance | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 6 | 56 |
GO:0000502 | proteasome complex | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 17 | 58 |
GO:0042995 | cell projection | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 6 | 60 |
GO:0019903 | protein phosphatase binding | 4.22e-02 | 1.00e+00 | 4.540 | 1 | 4 | 62 |
GO:0006302 | double-strand break repair | 4.22e-02 | 1.00e+00 | 4.540 | 1 | 4 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 22 | 65 |
GO:0006289 | nucleotide-excision repair | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 4.62e-02 | 1.00e+00 | 4.407 | 1 | 5 | 68 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 20 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 6 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.02e-02 | 1.00e+00 | 4.285 | 1 | 22 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 2 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 20 | 75 |
GO:0001889 | liver development | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 4 | 77 |
GO:0007565 | female pregnancy | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 1 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.35e-02 | 1.00e+00 | 4.190 | 1 | 23 | 79 |
GO:0019083 | viral transcription | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 10 | 81 |
GO:0047485 | protein N-terminus binding | 5.81e-02 | 1.00e+00 | 4.068 | 1 | 5 | 86 |
GO:0006415 | translational termination | 5.87e-02 | 1.00e+00 | 4.051 | 1 | 10 | 87 |
GO:0016605 | PML body | 5.94e-02 | 1.00e+00 | 4.035 | 1 | 3 | 88 |
GO:0016363 | nuclear matrix | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 12 | 91 |
GO:0006928 | cellular component movement | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 6.14e-02 | 1.00e+00 | 3.986 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 6 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 21 | 92 |
GO:0005515 | protein binding | 6.90e-02 | 1.00e+00 | 0.745 | 7 | 184 | 6024 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 7.05e-02 | 1.00e+00 | 3.780 | 1 | 3 | 105 |
GO:0072562 | blood microparticle | 7.44e-02 | 1.00e+00 | 3.700 | 1 | 3 | 111 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.63e-02 | 1.00e+00 | 3.661 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 7.70e-02 | 1.00e+00 | 3.649 | 1 | 13 | 115 |
GO:0000209 | protein polyubiquitination | 7.76e-02 | 1.00e+00 | 3.636 | 1 | 20 | 116 |
GO:0007568 | aging | 7.82e-02 | 1.00e+00 | 3.624 | 1 | 3 | 117 |
GO:0006006 | glucose metabolic process | 7.89e-02 | 1.00e+00 | 3.612 | 1 | 7 | 118 |
GO:0006325 | chromatin organization | 7.89e-02 | 1.00e+00 | 3.612 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 8.02e-02 | 1.00e+00 | 3.587 | 1 | 5 | 120 |
GO:0006260 | DNA replication | 8.08e-02 | 1.00e+00 | 3.575 | 1 | 9 | 121 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 8.40e-02 | 1.00e+00 | 3.517 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 8.60e-02 | 1.00e+00 | 3.483 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 8.72e-02 | 1.00e+00 | 3.461 | 1 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 9.11e-02 | 1.00e+00 | 3.396 | 1 | 10 | 137 |
GO:0007507 | heart development | 9.23e-02 | 1.00e+00 | 3.375 | 1 | 7 | 139 |
GO:0006457 | protein folding | 9.49e-02 | 1.00e+00 | 3.334 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 9.61e-02 | 1.00e+00 | 3.314 | 1 | 7 | 145 |
GO:0010628 | positive regulation of gene expression | 9.68e-02 | 1.00e+00 | 3.304 | 1 | 5 | 146 |
GO:0042981 | regulation of apoptotic process | 9.93e-02 | 1.00e+00 | 3.265 | 1 | 24 | 150 |
GO:0046777 | protein autophosphorylation | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 7 | 158 |
GO:0000287 | magnesium ion binding | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 4 | 164 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 7 | 165 |
GO:0030424 | axon | 1.09e-01 | 1.00e+00 | 3.119 | 1 | 4 | 166 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.12e-01 | 1.00e+00 | 3.076 | 1 | 20 | 171 |
GO:0004672 | protein kinase activity | 1.16e-01 | 1.00e+00 | 3.027 | 1 | 6 | 177 |
GO:0032403 | protein complex binding | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 10 | 183 |
GO:0003924 | GTPase activity | 1.29e-01 | 1.00e+00 | 2.872 | 1 | 12 | 197 |
GO:0005622 | intracellular | 1.35e-01 | 1.00e+00 | 2.801 | 1 | 6 | 207 |
GO:0006184 | GTP catabolic process | 1.39e-01 | 1.00e+00 | 2.753 | 1 | 12 | 214 |
GO:0005615 | extracellular space | 1.39e-01 | 1.00e+00 | 1.592 | 2 | 17 | 957 |
GO:0008270 | zinc ion binding | 1.49e-01 | 1.00e+00 | 1.533 | 2 | 12 | 997 |
GO:0043025 | neuronal cell body | 1.57e-01 | 1.00e+00 | 2.558 | 1 | 9 | 245 |
GO:0044822 | poly(A) RNA binding | 1.63e-01 | 1.00e+00 | 1.450 | 2 | 49 | 1056 |
GO:0004842 | ubiquitin-protein transferase activity | 1.63e-01 | 1.00e+00 | 2.500 | 1 | 6 | 255 |
GO:0042493 | response to drug | 1.80e-01 | 1.00e+00 | 2.344 | 1 | 13 | 284 |
GO:0005856 | cytoskeleton | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 12 | 291 |
GO:0016567 | protein ubiquitination | 1.87e-01 | 1.00e+00 | 2.290 | 1 | 5 | 295 |
GO:0005525 | GTP binding | 1.95e-01 | 1.00e+00 | 2.218 | 1 | 12 | 310 |
GO:0007411 | axon guidance | 2.00e-01 | 1.00e+00 | 2.177 | 1 | 13 | 319 |
GO:0005524 | ATP binding | 2.25e-01 | 1.00e+00 | 1.152 | 2 | 60 | 1298 |
GO:0005925 | focal adhesion | 2.27e-01 | 1.00e+00 | 1.978 | 1 | 19 | 366 |
GO:0007155 | cell adhesion | 2.28e-01 | 1.00e+00 | 1.967 | 1 | 6 | 369 |
GO:0046982 | protein heterodimerization activity | 2.34e-01 | 1.00e+00 | 1.924 | 1 | 13 | 380 |
GO:0005737 | cytoplasm | 2.51e-01 | 1.00e+00 | 0.615 | 4 | 110 | 3767 |
GO:0055114 | oxidation-reduction process | 2.56e-01 | 1.00e+00 | 1.780 | 1 | 12 | 420 |
GO:0043066 | negative regulation of apoptotic process | 2.58e-01 | 1.00e+00 | 1.766 | 1 | 31 | 424 |
GO:0007596 | blood coagulation | 2.74e-01 | 1.00e+00 | 1.664 | 1 | 18 | 455 |
GO:0042802 | identical protein binding | 2.89e-01 | 1.00e+00 | 1.575 | 1 | 20 | 484 |
GO:0005730 | nucleolus | 3.18e-01 | 1.00e+00 | 0.814 | 2 | 69 | 1641 |
GO:0006915 | apoptotic process | 3.25e-01 | 1.00e+00 | 1.378 | 1 | 33 | 555 |
GO:0042803 | protein homodimerization activity | 3.44e-01 | 1.00e+00 | 1.277 | 1 | 12 | 595 |
GO:0045087 | innate immune response | 3.44e-01 | 1.00e+00 | 1.275 | 1 | 24 | 596 |
GO:0005886 | plasma membrane | 5.58e-01 | 1.00e+00 | 0.160 | 2 | 45 | 2582 |